Heat Biologics Stock News

Squarepoint Ops LLC acquired a new stake in Heat Biologics, Inc. (NASDAQ:HTBX) in the 2nd quarter, HoldingsChannel.com reports. The firm acquired 18,807 shares of the biopharmaceutical companys stock, valued at approximately $127,000. Other large investors have also recently bought and sold shares of the company. Morgan Stanley increased its stake in shares of Heat Biologics []

Heat Biologics, Inc. (NASDAQ:HTBX) was the target of a large decline in short interest in the month of October. As of October 29th, there was short interest totalling 1,720,000 shares, a decline of 17.3% from the October 14th total of 2,080,000 shares. Based on an average daily trading volume, of 254,300 shares, the short-interest ratio []

Analysts forecast that Heat Biologics, Inc. (NASDAQ:HTBX) will announce earnings per share of ($0.30) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Heat Biologics earnings. The highest EPS estimate is ($0.30) and the lowest is ($0.31). The firm is expected to report its next quarterly earnings report on Wednesday, []

DURHAM, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate

DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune s

DURHAM, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune s

Conference call scheduled for September 2nd at 11:00 AM ET Conference call scheduled for September 2nd at 11:00 AM ET

Heat Biologics Inc. (NASDAQ:HTBX) shares traded higher Thursday morning after the company announced the launch of its wholly-owned subsidiary Skunkworx Bio Inc. focused on developing a drug discover

Developing a new era of precision medicines using a unique and proprietary drug discovery platform Developing a new era of precision medicines using a unique and proprietary drug discovery platform

DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate

DURHAM, N.C., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate

Groundbreaking ceremony to be streamed live Groundbreaking ceremony to be streamed live

Investments expected to accelerate development timelines and reduce development expenses Investments expected to accelerate development timelines and reduce development expenses

The stock price of Heat Biologics Inc (NASDAQ: HTBX) increased by 40.15%. This is why it happened.

Heat Biologics Inc. (NASDAQ:HTBX) shares traded higher Thursday after the company filed for a patent titled “GP96-Based Cancer Therapy.” The stock was trending on StockTwits throughout the day and